TALK KEYWORD INDEX
This page contains an index consisting of author-provided keywords.
| 1 | |
| 137Cs | |
| 155Tb | |
| 3 | |
| 3D bioprinting | |
| 3D cell cultures | |
| 3D liver bioscaffolds | |
| 3D spheroids | |
| 4 | |
| 4-MU | |
| 47Sc cross section | |
| 5 | |
| 53BP1 | |
| 6 | |
| 6-thio-dG | |
| A | |
| A549 lung carcinoma | |
| Abdominal aorta | |
| abscopal effect | |
| Accelerated ions | |
| accident dosimetry | |
| Acute Radiation Syndrome | |
| AD | |
| Adipose-derived stem cells | |
| adverse outcome pathways | |
| agonist | |
| agrospace | |
| alpha particles | |
| Alpha radiation | |
| alternative tumor models | |
| Aneurysm | |
| anthocyanins | |
| Antioxidant defense | |
| AOPs | |
| ApcMin/+ mouse | |
| apoptosis | |
| apoptosis inhibition | |
| aquatic biota | |
| ATAC-seq | |
| Atherosclerosis | |
| atlas | |
| automatic scoring | |
| B | |
| beam monitoring | |
| beam quality assurance | |
| Beta amyloid | |
| BIANCA | |
| Biodistribution | |
| Biodosimetry | |
| biofortification | |
| Biological Dosimetry | |
| biological effects | |
| biological response | |
| biomarker | |
| biomarkers | |
| Biomolecules | |
| biophysical model | |
| Biophysical Modeling | |
| BNCT | |
| Bomber effect | |
| boost radiotherapy | |
| boron | |
| Boron-Neutron Capture Therapy | |
| brachytherapy | |
| breast cancer | |
| Breast Cancer Cells | |
| breast cancer radiotherapy | |
| building material | |
| Bystander effects | |
| C | |
| caldera | |
| Campania | |
| Campi Flegrei | |
| Cancer | |
| cancer cells | |
| cancer model | |
| cancer risk | |
| Cancer stem cell | |
| Cancer Stem Cells | |
| cancer therapy | |
| carbon ion irradiation | |
| carbon ions | |
| carboplatin | |
| Carcinogenesis | |
| cardiovascular disease | |
| CBMN assay | |
| CBNM | |
| cdc2 | |
| cell biology | |
| cell cycle | |
| cell cycle distribution | |
| cell cycle progression | |
| Cell death | |
| Cell freezing/thawing | |
| Cell Therapy | |
| cell-cycle evaluation | |
| cGAS | |
| checkpoint kinase 1 | |
| Chernobyl exclusion zone | |
| childhood cancer survivors | |
| Chondrosarcoma | |
| chromatid breaks | |
| Chromosomal aberration | |
| chromosomal aberrations | |
| Chronic low doses | |
| Cigarette smoke | |
| Circulating Tumor Cells | |
| clinical beam | |
| Clinical implementation | |
| clonogenic assay | |
| clonogenic survival | |
| cognitive risks | |
| colon cancer | |
| Colorectal cancer | |
| communication | |
| concentration factors | |
| confocal | |
| coralyne | |
| cosmic radiation | |
| Cultural Heritage | |
| Curcumin | |
| CW/PW | |
| cyclotron-based radiopharmaceuticals | |
| CZT | |
| D | |
| DAP3 | |
| Data Hub | |
| DDR inhibitors | |
| deep-learning | |
| development of countermeasures | |
| diatom | |
| dicentric chromosome assay | |
| direct and indirect effects | |
| DMSO | |
| DNA damage | |
| DNA damage and repair | |
| DNA damage response | |
| DNA methylation | |
| DNA repair | |
| DNA/chromatin damage | |
| dose and dose rate effectiveness factor (DDREF) | |
| dose monitoring | |
| Dose-rate | |
| dosimetric audit | |
| dosimetric properties | |
| dosimetry | |
| DOTATATE | |
| drug delivery | |
| dSTORM | |
| E | |
| early and late effects | |
| electromagnetic exposure | |
| electromagnetic sensitivity | |
| Elephants | |
| Embryogenesis | |
| EMF/RF-EMF | |
| Energy metabolism | |
| Environmental radioactivity | |
| Evolutionary Biology | |
| exosomes | |
| Experimental and simulated data | |
| exposure evaluation | |
| Extracellular vesicle | |
| extracellular vesicles | |
| F | |
| FBPA | |
| ferritin | |
| fibroblasts | |
| filtration | |
| FLASH | |
| FLASH irradiation | |
| FLASH mechanism | |
| FLASH Proton Therapy | |
| FLASH radiotherapy | |
| FLUKA Monte Carlo | |
| fluorescent in situ hybridization (FISH) | |
| fractionated radiotherapy | |
| G | |
| G-quadruplex ligand | |
| G2 arrest | |
| G2 chromosomal radiosensitvity assay | |
| G2-M checkpoint | |
| Gafchromic EBT3 film | |
| galactic cosmic ray solar modulation | |
| gamma irradiation | |
| gamma radiation | |
| Geant4 | |
| Geant4-DNA | |
| gene and protein expression | |
| gene expression | |
| Gene Expression Profile | |
| genetics | |
| genomic instability | |
| Genotoxicity | |
| GEP-NET | |
| GIS | |
| Glioblastoma | |
| gold nanoparticles | |
| gold nanorods | |
| GPU | |
| GRID irradiation | |
| H | |
| H2AX | |
| Hadrontherapy | |
| hairy root cultures | |
| HAS3 | |
| head and neck | |
| head and neck cancer | |
| head and neck cancer cells | |
| head and neck cancer patients | |
| health professionals | |
| heavy ion radiobiology | |
| heavy ions | |
| helium ions | |
| hematological effects | |
| hibernation | |
| high dose-rates | |
| High LET | |
| high LET radiation | |
| high-LET | |
| high-resolution microscopy | |
| Histone deacetylase inhibitors (HDACi) | |
| human blood | |
| Human space exploration | |
| Human Spaceflight | |
| hyaluronan | |
| hyaluronic acid | |
| Hydroxyl radical | |
| Hyper-radiosensitivity | |
| I | |
| image guidance | |
| Immune cell recruitment | |
| immune dysfunction | |
| Immune escape | |
| immune modulation | |
| immune phenotyping | |
| immune response | |
| immune system | |
| immunohistochemistry | |
| immunotherapy | |
| IMPT | |
| in vitro | |
| in vitro measurements | |
| in vivo studies | |
| individual variation | |
| Induced radioresistance | |
| Inflammation | |
| instillation | |
| Intercellular communication | |
| Interphase nucleus | |
| Intestinal cancer | |
| Intestine | |
| intra- and intercellular sensitivity | |
| iodine | |
| ion imaging | |
| ionisation cluster size distribution | |
| Ionising radiation | |
| Ionizing radiation | |
| ionizing radiation-induced (repair) foci (IRIF) chromatin micro and nano-architecture | |
| Ionizing Radiation-Induced Foci (IRIFs) | |
| ionizing radiations | |
| IORT | |
| irradiation | |
| J | |
| Juvenile | |
| K | |
| kidney cancer | |
| KRAS mutation | |
| L | |
| Laser accelerated beams | |
| LET | |
| Leukaemia | |
| Leukemia | |
| Linear-quadratic model | |
| live-cell imaging | |
| live-cell phase-contrast-microscopy | |
| localization microscopy | |
| localized radiation injury | |
| low and high LET | |
| low dose | |
| low dose rate | |
| Low doses | |
| Low LET | |
| low LET radiation | |
| Low-dose fractionated radiation | |
| Low-dose radiation | |
| low-energy protons | |
| luminescence methods | |
| Lunar Gateway | |
| Lutathera | |
| Lymphocytes | |
| M | |
| manganese | |
| Mathematical modelling | |
| MCMC-tracking | |
| mechanistic investigation | |
| Medical countermeasure | |
| MEDIRAD EARLY-HEART cohort | |
| Metabolism | |
| metabolism alteration | |
| metabolomics | |
| metal nanoparticles (MP) | |
| mice | |
| micro-PET/CT | |
| Microbeam Radiation Therapy | |
| Microbeam radiotherapy | |
| Microdosimetric Kinetic Model | |
| Microdosimetry | |
| Microenvironment | |
| Microglia | |
| Microglial cells | |
| microgravity | |
| micronuclei | |
| micronucleus assay | |
| microRNA | |
| microscopy | |
| MicroTom | |
| Microtubules | |
| migration | |
| miRNA | |
| Mitochondria | |
| mixed beams | |
| modelling | |
| modifiable risk factors | |
| Molecular effects | |
| molecular imaging | |
| Monocytes | |
| Monte Carlo | |
| Monte Carlo Simulation | |
| Monte Carlo simulations | |
| MonteCarlo | |
| mouse imaging | |
| MRT | |
| mucosal melanoma | |
| multimodal data integration | |
| Mutation induction | |
| N | |
| nano-systems | |
| nanodiamonds | |
| nanodosimetry | |
| nanoparticle-enhanced cancer radiotherapy | |
| Nanoparticles | |
| nanoparticles internalization | |
| NBS1 foci | |
| NCT | |
| Neuroblastoma | |
| Nicotine | |
| non-human biota | |
| non-invasive biomarkers | |
| non-ionizing exposure | |
| Non-Ionizing Radiation | |
| non-reference dosimetry | |
| non-targeted effects | |
| Normal tissue sparing | |
| Normal tissue toxicity | |
| Nrf2 | |
| NSCLC | |
| NTCP | |
| nuclear medicine | |
| nuclear reaction modeling | |
| O | |
| occupational exposure | |
| Olfactory function | |
| Online range verification | |
| Organoids | |
| Oxidative stress | |
| oxidized protein | |
| oxygen effect | |
| P | |
| p21 | |
| paclitaxel | |
| pancreatic carcinoma | |
| PARP inhibitor | |
| Parp1 | |
| Particle therapy | |
| patients | |
| Payloads | |
| PBCT | |
| percentage depth dose distribution | |
| peripheral blood lymphocytes | |
| persistence homology | |
| PET | |
| Peto’s Paradox | |
| photons | |
| phytoplankton | |
| plasma | |
| PPAR alpha | |
| PRDM1 | |
| Preclinical research | |
| pregnancy | |
| preservation | |
| primary immunodeficiencies | |
| prompt gamma | |
| prostate cancer | |
| proteasome | |
| Protein glycosylation | |
| proteins | |
| proteomics | |
| Proton Boron Capture Therapy | |
| Proton Irradiation | |
| proton minibeam radiotherapy | |
| proton therapy | |
| proton tomography | |
| Proton-Boron-Fluorine Enhanced Protontherapy (PBFEPT) | |
| protons | |
| protons irradiations | |
| protontherapy | |
| PRRT | |
| psoriasis | |
| psychological stress | |
| R | |
| Radiation | |
| Radiation Chemistry | |
| radiation effects | |
| radiation exposure | |
| radiation physics | |
| radiation protection | |
| Radiation response | |
| radiation risk | |
| radiation sensitivity | |
| radiation susceptibility | |
| radiation therapy | |
| radiation-induced effects | |
| radiation-risk mitigation | |
| radio-induced damage | |
| radio-induced DNA damage | |
| radioactive contamination | |
| Radioactive Ion Beams | |
| radiobilogical effects | |
| radiobiological hypoxia | |
| radiobiology | |
| radiocommunication networks | |
| radioconjugates | |
| radiolabeling | |
| radiology | |
| Radiolysis | |
| radiomics | |
| Radiomitigation | |
| radionuclide therapy | |
| radiopharmaceutical | |
| Radioprotection | |
| radioprotective agents | |
| Radioresistance | |
| radioresistant cancer cells | |
| radioresistant tumors | |
| radiosensitivity | |
| Radiosensitization | |
| radiosensitizers | |
| Radiotherapy | |
| Radiotherapy damage | |
| radiotherapy photon beams | |
| Radon | |
| radon indoor | |
| radon map | |
| Radon progeny | |
| Radon solubility | |
| radon therapy | |
| Raman spectroscopy | |
| RBE | |
| relative biological effectiveness | |
| resin process | |
| Resistance to therapy | |
| Retrospective dosimetry | |
| RF-EMF | |
| RHPS4 | |
| Ripley´s distance statistics | |
| risk assessment | |
| RNA sequencing | |
| RNA-binding protein | |
| RNA-Sequencing Analysis | |
| RNAseq | |
| robotic space exploration | |
| ROS distribution | |
| Rradionuclide therapy | |
| S | |
| scRNA-seq | |
| second cancer | |
| Secondary cancer | |
| Sexes | |
| side-effects | |
| signal transduction | |
| silicon carbide detector | |
| simulation | |
| simulation models | |
| single-molecule localization microscopy (SMLM) | |
| solar physics | |
| somatostatin | |
| Somatostatin analogues | |
| space exploration | |
| space radiation | |
| space radiation research | |
| Space Weather | |
| spaceflight | |
| Spatial radiotherapy | |
| Spatially fractionated radiation therapy | |
| Stealth effect | |
| Stem cells | |
| stopping power | |
| strain imaging | |
| Stromal vascular fraction | |
| sub-cellular dosimetry | |
| Synergic effects | |
| synthetic torpor | |
| systems biology | |
| T | |
| tandem accelerator | |
| TBI | |
| telomerase | |
| Telomere | |
| telomeres | |
| theragnostic | |
| theranostics | |
| thermoluminescence | |
| time series | |
| tissues radioresponse | |
| TLD | |
| tomography | |
| TOPAS | |
| Total Body Irradiation | |
| TP53 | |
| TPS | |
| Track Structure | |
| Transcription | |
| Translation | |
| TRAX-Chem | |
| Treatment Plan | |
| treatment planning | |
| treatment verification | |
| Triple Negative Breast Cancer | |
| Tritium | |
| Tumor cell radiosensitization | |
| Tumor cells | |
| Tumor cryoablation | |
| tumor hypoxia | |
| Tumor microenvironment | |
| Tumour response | |
| U | |
| U2OS | |
| Ultra high dose rate | |
| Ultra-high dose rate | |
| Uranium | |
| V | |
| V79 | |
| Vascular endothelium | |
| vascular system | |
| VE-821 | |
| W | |
| Water radiolysis | |
| workers safety | |
| X | |
| X-ray beam quality | |
| X-rays | |
| Xenografted mice | |
| Y | |
| Yield of hydrated electron | |
| Z | |
| Zebrafish | |
| zinc | |
| α | |
| α+γ spectrometry | |
| α-spectrometry | |
| γ | |
| γ-H2AX foci assay | |
| γH2AX foci | |